Patent US4165325A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4165325A Expired / Lapsed US ⏱️ 0.0 years remaining

11-Deoxy-trans-4,5,13,14-tetradehydro-PGI1 compounds

Assignee: Pharmacia and Upjohn Co
•
Filing: 1978-06-14
•
Granted: 1979-08-21
•
Expires: 1998-06-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to certain structural and pharmacological analogs of prostacyclin (PGI 2 ) which are 11-deoxy-trans-4,5,13,14-tetradehydro-PGI 1 compounds. These novel pharmacological agents are useful as smooth muscle stimulators.

Inventors

  • 👤 Herman W. Smith

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 11:20
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/77; C07D307/93; C07D307/935; C07D307/937; C07D311/00; C07D311/02; C07D311/94

Claims Analysis

Total Claims: 73
Claim 1
Independent Claim 730 words
A prostacyclin analog of the formula ##STR1## wherein Y 2 is -C.tbd.C-; wherein Z 2 is ##STR2## wherein Z 1 is (1) -(CH 2 ) g -CH 2 -CH 2 -, or (2) -(CH 2 ) g -CH 2 -CF 2 -, wherein g is the integer zero, one, or 2; wherein R 8 is hydrogen or hydroxymethyl; wherein M 1 is ##STR3## wherein R 5 is hydrogen or alkyl with one to 4 carbon atoms, inclusive, Wherein L 1 is ##STR4## or a mixture of ##STR5## and ##STR6## wherein R 3 and R 4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R 3 and R 4 is fluoro only when the other is hydrogen or fluoro; Wherein X 1 is (1) -COOR 1 wherein R 1 is hydrogen; alkyl of one to 12 carbon atoms, inclusive; cycloalkyl of 3 to 10 carbon atoms, inclusive; aralkyl of 7 to 12 carbon atoms, inclusive; phenyl; phenyl substituted with one, two or three chloro or alkyl of one to 3 carbon atoms; phenyl substituted in the para position by ##STR7## WHEREIN R 25 is methyl, phenyl, acetamidophenyl, benzamidophenyl, or -NH 2 ; R 26 is methyl, phenyl, -NH 2 , or methoxy; and R 27 is hydrogen or acetamido; inclusive, phenacyl, i.e., ##STR8## phenacyl substituted in the para position by chloro, bromo, phenyl, or benzamido; or a pharmacologically acceptable cation; (2) -CH 2 OH; (3) -ch 2 nl 2 l 3 , wherein L 2 and L 3 are hydrogen or alkyl of one to 4 carbon atoms inclusive or (4) -COL 4 , wherein L 4 is (a) amino of the formula -NR 21 R 22 ; wherein R 21 and R 22 are hydrogen; alkyl of one to 12 carbon atoms, inclusive; cycloalkyl of 3 to 10 carbon atoms, inclusive aralkyl of 7 to 12 carbon atoms, inclusive; phenyl; phenyl substituted with one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive: hydroxy, carboxy, alkoxycarbonyl of one to 4 carbon atoms, inclusive, or nitro; carboxyalkyl of one to 4 carbon atoms, inclusive, carbamoylalkyl of one to 4 carbon atoms, inclusive; cyanoalkyl of one to 4 carbon atoms, inclusive: acetylalkyl of one to 4 carbon atoms, inclusive; benzoylalkyl of one to 4 carbon atoms, inclusive; benzoylalkyl substituted by one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive, hydroxy, alkoxy of one to 3 carbon atoms, inclusive, carboxy, alkoxycarbonyl of one to 4 carbon atoms, inclusive; or nitro; pyridyl; pyridyl substituted by one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive; pyridylalkyl of one to 4 carbon atoms, inclusive; pyridylalkyl substituted by one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive, hydroxy, or alkoxy of one to 3 carbon atoms, inclusive; hydroxyalkyl of one to 4 carbon atoms, inclusive; dihydroxylakyl of one to 4 carbon atoms, and trihydroxyalkyl of one to 4 carbon atoms; with the further proviso that not more than one of R 21 and R 22 is other than hydrogen or alkyl; (b) cycloamino selected from the group consisting of ##STR9## wherein R 21 and R 22 are as defined above; (c) carbonylamino of the formula -NR 23 COR 21 , wherein R 23 is hydrogen or alkyl of one to 4 carbon atoms and R 21 is as defined above; (d) sulfonylamino of the formula -NR 23 SO 2 R 21 , wherein R 21 and R 23 are as defined above; or (e) hydrazino of the formula -NR 23 R 24 , wherein R 23 is as defined above and R 24 is amino of the formula -NR 21 R 22 , as defined above, or cycloamino, as defined above; wherein R 7 is (1) -(CH 2 ) m -CH 3 , ##STR10## wherein m is the integer one to 5, inclusive, h is the integer zero to 3 inclusive; s is the integer zero, one, 2, or 3, and T is chloro, fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive, with the proviso that not more than two T's are other than alkyl; and the pharmacologically acceptable acid addition salts thereof when Z 1 is -CH 2 NL 2 L 3 .
Claim 2
Dependent Claim 730 words
A prostacyclin analog of the formula ##STR1## wherein Y 2 is -C.tbd.C-; wherein Z 2 is ##STR2## wherein Z 1 is (1) -(CH 2 ) g -CH 2 -CH 2 -, or (2) -(CH 2 ) g -CH 2 -CF 2 -, wherein g is the integer zero, one, or 2; wherein R 8 is hydrogen or hydroxymethyl; wherein M 1 is ##STR3## wherein R 5 is hydrogen or alkyl with one to 4 carbon atoms, inclusive, Wherein L 1 is ##STR4## or a mixture of ##STR5## and ##STR6## wherein R 3 and R 4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R 3 and R 4 is fluoro only when the other is hydrogen or fluoro; Wherein X 1 is (1) -COOR 1 wherein R 1 is hydrogen; alkyl of one to 12 carbon atoms, inclusive; cycloalkyl of 3 to 10 carbon atoms, inclusive; aralkyl of 7 to 12 carbon atoms, inclusive; phenyl; phenyl substituted with one, two or three chloro or alkyl of one to 3 carbon atoms; phenyl substituted in the para position by ##STR7## WHEREIN R 25 is methyl, phenyl, acetamidophenyl, benzamidophenyl, or -NH 2 ; R 26 is methyl, phenyl, -NH 2 , or methoxy; and R 27 is hydrogen or acetamido; inclusive, phenacyl, i.e., ##STR8## phenacyl substituted in the para position by chloro, bromo, phenyl, or benzamido; or a pharmacologically acceptable cation; (2) -CH 2 OH; (3) -ch 2 nl 2 l 3 , wherein L 2 and L 3 are hydrogen or alkyl of one to 4 carbon atoms inclusive or (4) -COL 4 , wherein L 4 is (a) amino of the formula -NR 21 R 22 ; wherein R 21 and R 22 are hydrogen; alkyl of one to 12 carbon atoms, inclusive; cycloalkyl of 3 to 10 carbon atoms, inclusive aralkyl of 7 to 12 carbon atoms, inclusive; phenyl; phenyl substituted with one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive: hydroxy, carboxy, alkoxycarbonyl of one to 4 carbon atoms, inclusive, or nitro; carboxyalkyl of one to 4 carbon atoms, inclusive, carbamoylalkyl of one to 4 carbon atoms, inclusive; cyanoalkyl of one to 4 carbon atoms, inclusive: acetylalkyl of one to 4 carbon atoms, inclusive; benzoylalkyl of one to 4 carbon atoms, inclusive; benzoylalkyl substituted by one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive, hydroxy, alkoxy of one to 3 carbon atoms, inclusive, carboxy, alkoxycarbonyl of one to 4 carbon atoms, inclusive; or nitro; pyridyl; pyridyl substituted by one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive; pyridylalkyl of one to 4 carbon atoms, inclusive; pyridylalkyl substituted by one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive, hydroxy, or alkoxy of one to 3 carbon atoms, inclusive; hydroxyalkyl of one to 4 carbon atoms, inclusive; dihydroxylakyl of one to 4 carbon atoms, and trihydroxyalkyl of one to 4 carbon atoms; with the further proviso that not more than one of R 21 and R 22 is other than hydrogen or alkyl; (b) cycloamino selected from the group consisting of ##STR9## wherein R 21 and R 22 are as defined above; (c) carbonylamino of the formula -NR 23 COR 21 , wherein R 23 is hydrogen or alkyl of one to 4 carbon atoms and R 21 is as defined above; (d) sulfonylamino of the formula -NR 23 SO 2 R 21 , wherein R 21 and R 23 are as defined above; or (e) hydrazino of the formula -NR 23 R 24 , wherein R 23 is as defined above and R 24 is amino of the formula -NR 21 R 22 , as defined above, or cycloamino, as defined above; wherein R 7 is (1) -(CH 2 ) m -CH 3 , ##STR10## wherein m is the integer one to 5, inclusive, h is the integer zero to 3 inclusive; s is the integer zero, one, 2, or 3, and T is chloro, fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive, with the proviso that not more than two T's are other than alkyl; and the pharmacologically acceptable acid addition salts thereof when Z 1 is -CH 2 NL 2 L 3 .
Claim 3
Dependent Claim 12 words
A prostacyclin analog according to claim 1, wherein R 8 is hydroxymethyl.
Claim 4
Dependent Claim 15 words
A prostacyclin analog according to claim 2, wherein Z 2 is a mixture of ##STR11##
Claim 5
Dependent Claim 8 words
trans-4,5,13,14-Tetradehydro-(6RS)-11-deoxy-11α-hydroxymethyl-PGI.sub.1, a prostacyclin analog according to claim 3.
Claim 6
Dependent Claim 12 words
A prostacyclin analog according to claim 2, wherein Z 2 is ##STR12##
Claim 7
Dependent Claim 10 words
trans-4,5,13,14-Tetradehydro-6α-11-deoxy-11α-hydroxymethyl-PGI 1 , a prostacyclin analog according to claim 5.
Claim 8
Dependent Claim 10 words
15-Methyl-trans-4,5,13,14-tetradehydro-6α-11-deoxy-11α-hydroxymethyl-PGI 1 , a prostacyclin analog according to claim 5.
Claim 9
Dependent Claim 10 words
16,16-Dimethyl-trans-4,5,13,14-tetradehydro-6α-11-deoxy-11α-hydroxymethyl-PGI 1 , a prostacyclin analog according to claim 5.
Claim 10
Dependent Claim 10 words
16,16-Difluoro-trans-4,5,13,14-tetrahydro-6α-11-deoxy-11α-hydroxymethyl-PGI 1 , a prostacyclin analog according to claim 5.
Claim 11
Dependent Claim 12 words
A prostacyclin analog according to claim 2, wherein Z 2 is ##STR13##
Claim 12
Dependent Claim 20 words
A prostacyclin analog according to claim 10, wherein Z 1 is -(CH 2 ) g -CH 2 -CF 2 -.
Claim 13
Dependent Claim 10 words
2,2-Difluoro-trans-4,5,13,14-tetradehydro-6β-11-deoxy-11α-hydroxymethyl-PGI 1 , a prostacyclin analog according to claim 11.
Claim 14
Dependent Claim 20 words
A prostacyclin analog according to claim 10, wherein Z 1 is -(CH 2 ) g -CH 2 -CH 2 -.
Claim 15
Dependent Claim 11 words
A prostacyclin analog according to claim 13, wherein g is zero.
Claim 16
Dependent Claim 12 words
A prostacyclin analog according to claim 14, wherein R 7 is ##STR14##
Claim 17
Dependent Claim 10 words
17-Phenyl-18,19,20-trinor-trans-4,5,13,14-tetradehydro-6β-11-deoxy-11α-hydroxymethyl-PGI 1 , a prostacyclin analog according to claim 15.
Claim 18
Dependent Claim 12 words
A prostacyclin analog according to claim 14, wherein R 7 is ##STR15##
Claim 19
Dependent Claim 10 words
16-Phenoxy-17,18,19,20-tetranor-trans-4,5,13,14-tetradehydro-6β-11-deoxy-11α-hydroxymethyl-PGI 1 , a prostacyclin analog according to claim 17.
Claim 20
Dependent Claim 18 words
A prostacyclin analog according to claim 14, wherein R 7 is -(CH 2 ) m -CH 3 -.
Claim 21
Dependent Claim 11 words
A prostacyclin analog according to claim 19, wherein m is 3.
Claim 22
Dependent Claim 14 words
A prostacyclin analog according to claim 20, wherein X 1 is -COL 4 .
Claim 23
Dependent Claim 10 words
trans-4,5,13,14-Tetradehydro-6β-11-deoxy-11α-hydroxymethyl-PGI 1 amide, a prostacyclin analog according to claim 21.
Claim 24
Dependent Claim 14 words
A prostacyclin analog according to claim 20, wherein X 1 is CH 2 OH-.
Claim 25
Dependent Claim 10 words
2-Decarboxy-2-hydroxymethyl-trans-4,5,13,14-tetradehydro-6β-11-deoxy-11α-hydroxymethyl-PGI 1 , a prostacyclin analog according to claim 23.
Claim 26
Dependent Claim 14 words
A prostacyclin analog according to claim 20, wherein X 1 is -COOR 1 .
Claim 27
Dependent Claim 12 words
A prostacyclin analog according to claim 25, wherein R 5 is methyl.
Claim 28
Dependent Claim 10 words
15-Methyl-trans-4,5,13,14-tetradehydro-6β-11-deoxy-11α-hydroxymethyl-PGI 1 , a prostacyclin analog according to claim 26.
Claim 29
Dependent Claim 12 words
A prostacyclin analog according to claim 25, wherein R 5 is hydrogen.
Claim 30
Dependent Claim 19 words
A prostacyclin analog according to claim 28, wherein at least one of R 3 and R 4 is fluoro.
Claim 31
Dependent Claim 10 words
16,16-Difluoro-trans-4,5,13,14-tetradehydro-6β-11-deoxy-11α-hydroxymethyl-PGI 1 , a prostacyclin analog according to claim 29.
Claim 32
Dependent Claim 19 words
A prostacyclin analog according to claim 28, wherein at least one of R 3 and R 4 is methyl.
Claim 33
Dependent Claim 10 words
16,16-Dimethyl-trans-4,5,13,14-tetradehydro-6β-11-deoxy-11α-hydroxymethyl-PGI 1 , a prostacyclin analog according to claim 31.
Claim 34
Dependent Claim 16 words
A prostacyclin analog according to claim 28, wherein R 3 and R 4 are both hydrogen.
Claim 35
Dependent Claim 12 words
trans-4,5,13,14-Tetradehydro-6β-11-deoxy-11α-hydroxymethyl-PGI 1 , methyl ester, a prostacyclin analog according to claim 33.
Claim 36
Dependent Claim 13 words
trans-4,5,13,14-Tetradehydro-6β-11-deoxy-11α-hydroxymethyl-PGI 1 , tris(hydroxymethyl)amino methane salt, a prostacyclin analog according to claim 33.
Claim 37
Dependent Claim 12 words
trans-4,5,13,14-Tetradehydro-6β-11-deoxy-11α-hydroxymethyl-PGI 1 , adamantanamine salt, a prostacyclin analog according to claim 33.
Claim 38
Dependent Claim 10 words
trans-4,5,13,14-Tetradehydro-6β-11-deoxy-11α-hydroxymethyl-PGI 1 , a prostacyclin analog according to claim 33.
Claim 39
Dependent Claim 12 words
A prostacyclin analog according to claim 1, wherein R 8 is hydrogen.
Claim 40
Dependent Claim 15 words
A prostacyclin analog according to claim 38, wherein Z 2 is a mixture of ##STR16##
Claim 41
Dependent Claim 10 words
trans-4,5,13,14-Tetradehydro-(6RS)-11-deoxy-PGI 1 , a prostacyclin analog according to claim 39.
Claim 42
Dependent Claim 12 words
A prostacyclin analog according to claim 38, wherein Z 2 is ##STR17##
Claim 43
Dependent Claim 10 words
trans-4,5,13,14-Tetradehydro-6α-11-deoxy-PGI 1 , a prostacyclin analog according to claim 41.
Claim 44
Dependent Claim 10 words
15-Methyl-trans-4,5,13,14-tetradehydro-6α-11-deoxy-PGI 1 , a prostacyclin analog according to claim 41.
Claim 45
Dependent Claim 10 words
16,16-Dimethyl-trans-4,5,13,14-tetradehydro-6α-11-deoxy-PGI 1 , a prostacyclin analog according to claim 41.
Claim 46
Dependent Claim 12 words
A prostacyclin analog according to claim 38, wherein Z 2 is ##STR18##
Claim 47
Dependent Claim 20 words
A prostacyclin analog according to claim 45, wherein Z 1 is -(CH 2 ) g -CH 2 -CF 2 -.
Claim 48
Dependent Claim 10 words
2,2-Difluoro-trans-4,5,13,14-tetradehydro-6β-11-deoxy-PGI 1 , a prostacyclin analog according to claim 46.
Claim 49
Dependent Claim 20 words
A prostacyclin analog according to claim 45, wherein Z 1 is -(CH 2 ) g -CH 2 -CH 2 -.
Claim 50
Dependent Claim 11 words
A prostacyclin analog according to claim 48, wherein g is zero.
Claim 51
Dependent Claim 12 words
A prostacyclin analog according to claim 49, wherein R 7 is ##STR19##
Claim 52
Dependent Claim 10 words
17-Phenyl-18,19,20-trinor-trans-4,5,13,14-tetradehydro-6β-11-deoxy-PGI 1 , a prostacyclin analog according to claim 50.
Claim 53
Dependent Claim 12 words
A prostacyclin analog according to claim 49, wherein R 7 is ##STR20##
Claim 54
Dependent Claim 10 words
16-Phenoxy-17,18,19,20-tetranor-trans-4,5,13,14-tetradehydro-6β-11-deoxy-PGI 1 , a prostacyclin analog according to claim 52.
Claim 55
Dependent Claim 18 words
A prostacyclin analog according to claim 49, wherein R 7 is -(CH 2 ) m -CH 3 -.
Claim 56
Dependent Claim 11 words
A prostacyclin analog according to claim 54, wherein m is 3.
Claim 57
Dependent Claim 14 words
A prostacyclin analog according to claim 55, wherein X 1 is -COL 4 .
Claim 58
Dependent Claim 10 words
trans-4,5,13,14-Tetradehydro-6β-11-deoxy-PGI 1 amide, a prostacyclin analog according to claim 56.
Claim 59
Dependent Claim 14 words
A prostacyclin analog according to claim 55, wherein X 1 is CH 2 OH-.
Claim 60
Dependent Claim 10 words
2-Decarboxy-2-hydroxymethyl-trans-4,5,13,14-tetradehydro-6β-11-deoxy-PGI 1 , a prostacyclin analog according to claim 58.
Claim 61
Dependent Claim 14 words
A prostacyclin analog according to claim 55, wherein X 1 is -COOR 1 .
Claim 62
Dependent Claim 12 words
A prostacyclin analog according to claim 60, wherein R 5 is methyl.
Claim 63
Dependent Claim 10 words
15-Methyl-trans-4,5,13,14-tetradehydro-6β-11-deoxy-PGI 1 , a prostacyclin analog according to claim 61.
Claim 64
Dependent Claim 12 words
A prostacyclin analog according to claim 60, wherein R 5 is hydrogen.
Claim 65
Dependent Claim 19 words
A prostacyclin analog according to claim 63, wherein at least one of R 3 and R 4 is fluoro.
Claim 66
Dependent Claim 10 words
16,16-Difluoro-trans-4,5,13,14-tetradehydro-6β-11-deoxy-PGI 1 , a prostacyclin analog according to claim 64.
Claim 67
Dependent Claim 19 words
A prostacyclin analog according to claim 63, wherein at least one of R 3 and R 4 is methyl.
Claim 68
Dependent Claim 10 words
16,16-Dimethyl-trans-4,5,13,14-tetradehydro-6β-11-deoxy-PGI 1 , a prostacyclin analog according to claim 66.
Claim 69
Dependent Claim 16 words
A prostacyclin analog according to claim 63, wherein R 3 and R 4 are both hdrogen.
Claim 70
Dependent Claim 12 words
trans-4,5,13,14-Tetradehydro-6β-11-deoxy-PGI 1 , methyl ester, a prostacyclin analog according to claim 68.
Claim 71
Dependent Claim 13 words
trans-4,5,13,14-Tetradehydro-6β-11-deoxy-PGI 1 , tris-(hydroxymethyl)amino methane salt, a prostacyclin analog according to claim 68.
Claim 72
Dependent Claim 12 words
trans-4,5,13,14-Tetradehydro-6β-11-deoxy-PGI 1 , adamantanamine salt, a prostacyclin analog according to claim 68.
Claim 73
Dependent Claim 10 words
trans-4,5,13,14-Tetradehydro-6β-11-deoxy-PGI 1 , a prostacyclin analog according to claim 68.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-08-20 1983-02-19 1983-08-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-08-20 1987-02-19 1987-08-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-08-20 1991-02-19 1991-08-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag